Skip to main content
Premium Trial:

Request an Annual Quote

Lion s Revenues Decline Sharply in Q2 of FY05, Loss Narrows

NEW YORK, Nov. 4 (GenomeWeb News) - Lion Bioscience today reported a sharp revenue downturn for its second fiscal quarter, while the company cut its loss in half.


Lion booked €2.6 million ($3.4 million) in revenues for the quarter ended Sept. 30, down from €5 million ($6.4 million) during the same period last year.


The company did not state its R&D expenses for the quarter.


Lion's net loss for the quarter narrowed to €3.4 million from €6.5 million during the year-ago quarter. This reduction resulted from Lion's cost-cutting measures.


As of Sept. 30, Lion had €33.3 million in liquid assets.

The Scan

More Boosters for US

Following US Food and Drug Administration authorization, the Centers for Disease Control and Prevention has endorsed booster doses of the Moderna and Johnson & Johnson SARS-CoV-2 vaccines, the Washington Post writes.

From a Pig

A genetically modified pig kidney was transplanted into a human without triggering an immune response, Reuters reports.

For Privacy's Sake

Wired reports that more US states are passing genetic privacy laws.

Science Paper on How Poaching Drove Evolution in African Elephants

In Science this week: poaching has led to the rapid evolution of tuskless African elephants.